Heidi Health

Heidi Health is a privately held company founded in Melbourne, Australia, that makes Heidi, an ambient AI medical scribe. Heidi listens to a consultation, in person or over telehealth, and drafts the clinical note, referral letters and follow-up tasks for the clinician to review before anything reaches the patient record. It appears in the catalog as an AI vendor: the scribe is the product it sells, and any clinician can start on a free tier before moving to a paid plan. The company began in 2019 as Oscer, which built AI virtual patients for medical students, and turned to clinical documentation under chief executive and co-founder Dr Thomas Kelly.

Its defining pattern is clinician-led freemium growth. Where Abridge built its business on health-system contracts, Heidi let individual doctors, nurses, dentists, allied health staff and even veterinarians sign up free, then sold team and enterprise plans once their organizations wanted to standardize. The company said it had supported 73 million patient consults by October 2025, and by July 2026 it described about 2.7 million patient interactions a week, in 110 languages across more than 100 countries.

The dated record is short and recent. In October 2025, Heidi closed a Series B of 65 million dollars led by Point72 Private Investments, with Blackbird, Headline and Latitude, which valued the company at 465 million dollars; by April 2026 it put its total funding at 96.6 million dollars. In February 2026 it acquired AutoMedica, a UK clinical AI company that had taken part in the AI Airlock sandbox run by the Medicines and Healthcare products Regulatory Agency (MHRA), and launched Heidi Evidence, which answers clinical questions with cited sources built with partners including NICE and BMJ Group. That second product puts it in closer competition with OpenEvidence as well as with other scribes.

The biggest health-system win came in April 2026, when Beth Israel Lahey Health extended Heidi to all of its physicians, about 6,000 providers across 14 hospitals and 175 primary care practices, after a six-month pilot. In that pilot, 74 percent of clinicians said their after-hours work had fallen and 89 percent said they were satisfied with note quality. Heidi says it is approved on Epic's Showroom and integrates with Oracle Cerner, and in July 2026 it formed a US customer advisory board of 12 physicians and clinical leaders.

The honest framing: Heidi's value rests on distribution, a free tier, broad language support and users far outside hospital medicine, layered on speech recognition and language models that turn conversation into notes, which is genuinely load-bearing machine learning. The measured results so far are self-reported survey figures from a customer pilot, not controlled trials of documentation time or note accuracy, and the weekly volume numbers are the company's own. The company does not claim FDA clearance for the scribe, so every note remains the clinician's responsibility. Among catalog peers, Abridge leads with deep Epic integration inside large health systems, while Heidi reached clinicians first and is now working its way up into the same enterprise contracts.